Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Nrf2 regulates angiogenesis: effect on endothelial cells, bone marrow-derived proangiogenic cells and hind limb ischemia.

Florczyk U, Jazwa A, Maleszewska M, Mendel M, Szade K, Kozakowska M, Grochot-Przeczek A, Viscardi M, Czauderna S, Bukowska-Strakova K, Kotlinowski J, Jozkowicz A, Loboda A, Dulak J.

Antioxid Redox Signal. 2014 Apr 10;20(11):1693-708. doi: 10.1089/ars.2013.5219.

2.

Heme oxygenase-1 is required for angiogenic function of bone marrow-derived progenitor cells: role in therapeutic revascularization.

Grochot-Przeczek A, Kotlinowski J, Kozakowska M, Starowicz K, Jagodzinska J, Stachurska A, Volger OL, Bukowska-Strakova K, Florczyk U, Tertil M, Jazwa A, Szade K, Stepniewski J, Loboda A, Horrevoets AJ, Dulak J, Jozkowicz A.

Antioxid Redox Signal. 2014 Apr 10;20(11):1677-92. doi: 10.1089/ars.2013.5426.

3.

Ablation of the transcription factor Nrf2 promotes ischemia-induced neovascularization by enhancing the inflammatory response.

Ichihara S, Yamada Y, Liu F, Murohara T, Itoh K, Yamamoto M, Ichihara G.

Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1553-61. doi: 10.1161/ATVBAHA.110.204123.

4.

Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells.

Huang PH, Chen CY, Lin CP, Wang CH, Tsai HY, Lo WY, Leu HB, Chen JW, Lin SJ, Chu PH.

Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):709-17. doi: 10.1161/ATVBAHA.112.300318.

5.

Pre-emptive hypoxia-regulated HO-1 gene therapy improves post-ischaemic limb perfusion and tissue regeneration in mice.

Jazwa A, Stepniewski J, Zamykal M, Jagodzinska J, Meloni M, Emanueli C, Jozkowicz A, Dulak J.

Cardiovasc Res. 2013 Jan 1;97(1):115-24. doi: 10.1093/cvr/cvs284.

6.

ATF3-mediated NRF2/HO-1 signaling regulates TLR4 innate immune responses in mouse liver ischemia/reperfusion injury.

Rao J, Qian X, Li G, Pan X, Zhang C, Zhang F, Zhai Y, Wang X, Lu L.

Am J Transplant. 2015 Jan;15(1):76-87. doi: 10.1111/ajt.12954.

7.

TGF-β1 signaling and Krüppel-like factor 10 regulate bone marrow-derived proangiogenic cell differentiation, function, and neovascularization.

Wara AK, Foo S, Croce K, Sun X, Icli B, Tesmenitsky Y, Esen F, Lee JS, Subramaniam M, Spelsberg TC, Lev EI, Leshem-Lev D, Pande RL, Creager MA, Rosenzweig A, Feinberg MW.

Blood. 2011 Dec 8;118(24):6450-60. doi: 10.1182/blood-2011-06-363713.

8.

Myoblast-conditioned media improve regeneration and revascularization of ischemic muscles in diabetic mice.

Kozakowska M, Kotlinowski J, Grochot-Przeczek A, Ciesla M, Pilecki B, Derlacz R, Dulak J, Jozkowicz A.

Stem Cell Res Ther. 2015 Apr 12;6:61. doi: 10.1186/s13287-015-0063-8.

9.

Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase.

Schröder K, Zhang M, Benkhoff S, Mieth A, Pliquett R, Kosowski J, Kruse C, Luedike P, Michaelis UR, Weissmann N, Dimmeler S, Shah AM, Brandes RP.

Circ Res. 2012 Apr 27;110(9):1217-25. doi: 10.1161/CIRCRESAHA.112.267054.

10.

Adoptive transfer of heme oxygenase-1 (HO-1)-modified macrophages rescues the nuclear factor erythroid 2-related factor (Nrf2) antiinflammatory phenotype in liver ischemia/reperfusion injury.

Huang J, Shen XD, Yue S, Zhu J, Gao F, Zhai Y, Busuttil RW, Ke B, Kupiec-Weglinski JW.

Mol Med. 2014 Oct 14;20:448-55. doi: 10.2119/molmed.2014.00103.

11.

PKCε-CREB-Nrf2 signalling induces HO-1 in the vascular endothelium and enhances resistance to inflammation and apoptosis.

Mylroie H, Dumont O, Bauer A, Thornton CC, Mackey J, Calay D, Hamdulay SS, Choo JR, Boyle JJ, Samarel AM, Randi AM, Evans PC, Mason JC.

Cardiovasc Res. 2015 Jun 1;106(3):509-19. doi: 10.1093/cvr/cvv131.

12.

Nuclear heme oxygenase-1 (HO-1) modulates subcellular distribution and activation of Nrf2, impacting metabolic and anti-oxidant defenses.

Biswas C, Shah N, Muthu M, La P, Fernando AP, Sengupta S, Yang G, Dennery PA.

J Biol Chem. 2014 Sep 26;289(39):26882-94. doi: 10.1074/jbc.M114.567685.

13.

PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors.

Kotlinowski J, Grochot-Przeczek A, Taha H, Kozakowska M, Pilecki B, Skrzypek K, Bartelik A, Derlacz R, Horrevoets AJ, Pap A, Nagy L, Dulak J, Jozkowicz A.

Cardiovasc Diabetol. 2014 Nov 1;13:150. doi: 10.1186/s12933-014-0150-7. Erratum in: Cardiovasc Diabetol. 2015;14:65.

14.

Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia.

Ungvari Z, Bailey-Downs L, Gautam T, Jimenez R, Losonczy G, Zhang C, Ballabh P, Recchia FA, Wilkerson DC, Sonntag WE, Pearson K, de Cabo R, Csiszar A.

Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1133-40. doi: 10.1152/ajpheart.00402.2010.

15.

Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2.

Ungvari Z, Bagi Z, Feher A, Recchia FA, Sonntag WE, Pearson K, de Cabo R, Csiszar A.

Am J Physiol Heart Circ Physiol. 2010 Jul;299(1):H18-24. doi: 10.1152/ajpheart.00260.2010.

16.

Kruppel-like factor 2 improves neovascularization capacity of aged proangiogenic cells.

Boon RA, Urbich C, Fischer A, Fontijn RD, Seeger FH, Koyanagi M, Horrevoets AJ, Dimmeler S.

Eur Heart J. 2011 Feb;32(3):371-7. doi: 10.1093/eurheartj/ehq137.

PMID:
20494899
17.

Molecular hydrogen protects mice against polymicrobial sepsis by ameliorating endothelial dysfunction via an Nrf2/HO-1 signaling pathway.

Chen H, Xie K, Han H, Li Y, Liu L, Yang T, Yu Y.

Int Immunopharmacol. 2015 Sep;28(1):643-54. doi: 10.1016/j.intimp.2015.07.034.

PMID:
26253656
18.

Hypoxia-responsive microRNA-101 promotes angiogenesis via heme oxygenase-1/vascular endothelial growth factor axis by targeting cullin 3.

Kim JH, Lee KS, Lee DK, Kim J, Kwak SN, Ha KS, Choe J, Won MH, Cho BR, Jeoung D, Lee H, Kwon YG, Kim YM.

Antioxid Redox Signal. 2014 Dec 20;21(18):2469-82. doi: 10.1089/ars.2014.5856.

19.

Bach1 Represses Wnt/β-Catenin Signaling and Angiogenesis.

Jiang L, Yin M, Wei X, Liu J, Wang X, Niu C, Kang X, Xu J, Zhou Z, Sun S, Wang X, Zheng X, Duan S, Yao K, Qian R, Sun N, Chen A, Wang R, Zhang J, Chen S, Meng D.

Circ Res. 2015 Jul 31;117(4):364-75. doi: 10.1161/CIRCRESAHA.115.306829. Erratum in: Circ Res. 2015 Oct 9;117(9):e79.

20.

TLR2-deficiency of cKit+ bone marrow cells is associated with augmented potency to stimulate angiogenic processes.

Wagner NM, Bierhansl L, Butschkau A, Noeldge-Schomburg G, Roesner JP, Vollmar B.

Int J Clin Exp Pathol. 2013 Nov 15;6(12):2813-23.

Items per page

Supplemental Content

Support Center